|
Volumn 155, Issue 2, 1997, Pages 221-222
|
Towards the development and use of human-selective agonists for the pharmacologic treatment of obesity and diabetes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA 3 ADRENERGIC RECEPTOR;
BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT;
CONFERENCE PAPER;
DIABETES MELLITUS;
DRUG EFFECT;
DRUG RECEPTOR BINDING;
DRUG SELECTIVITY;
DRUG SPECIFICITY;
ENERGY METABOLISM;
HUMAN;
NONHUMAN;
OBESITY;
PRIORITY JOURNAL;
THERMOGENESIS;
ADIPOCYTES;
ADRENERGIC BETA-AGONISTS;
ANIMALS;
BODY TEMPERATURE REGULATION;
DIABETES MELLITUS, TYPE 2;
ENERGY METABOLISM;
HUMANS;
MICE;
OBESITY;
RATS;
|
EID: 0030699218
PISSN: 00220795
EISSN: None
Source Type: Journal
DOI: 10.1677/joe.0.1550221 Document Type: Conference Paper |
Times cited : (4)
|
References (13)
|